GT-0198

a glycine transporter 2 (GlyT2) inhibitor with analgesic activity; structure in first source

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

1.	Pain (Aches) 03/01/2015 - "Intravenous, oral, and intrathecal injections of GT-0198 decreased the pain-related response in a model of neuropathic pain with partial sciatic nerve ligation. "
2.	Neuralgia (Stump Neuralgia) 03/01/2015 - "In summary, GT-0198 is a structurally novel GlyT2 inhibitor bearing a phenoxymethylbenzamide moiety with in vivo efficacy in behavioral models of neuropathic pain. " 03/01/2015 - "Intravenous, oral, and intrathecal injections of GT-0198 decreased the pain-related response in a model of neuropathic pain with partial sciatic nerve ligation. " 03/01/2015 - "Analgesic effect of GT-0198, a structurally novel glycine transporter 2 inhibitor, in a mouse model of neuropathic pain."

1.	Glycine Plasma Membrane Transport Proteins
2.	Analgesics (Analgesic Drugs)